About Neviah Genomics

About company

Neviah Genomics is the inventor and developer of PropheTox™, an innovative, ground-breaking drug toxicity screening service. Based on the mathematical analysis of cell behavior following exposure to multiple toxic and non-toxic compounds, PropheTox™ unique assay design and optimized decision support algorithms allow the detection of low-dose, chronic toxic effect, and fills a gap in the selection tools available today to drug discovery professionals.